Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues

Neuro-Oncology

Volumn 10, Issue 6, 2008, Pages 995-1003

  Kuga, Daisuke ^a   Mizoguchi, Masahiro ^a   Guan, Yanlei ^a   Hata, Nobuhiro ^a   Yoshimoto, Koji ^a   Shono, Tadahisa ^a   Suzuki, Satoshi O ^b   Kukita, Yoji ^a   Tahira, Tomoko ^a   Nagata, Shinji ^a   Sasaki, Tomio ^a   Hayashi, Kenshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Copy number alteration; Copy number neutral loh; Glioblastoma; Loss of heterozygosity; Single nucleotide polymorphism array

Indexed keywords

ADULT; AGED; ARTICLE; AUTOSOME; CHILD; CLINICAL ARTICLE; CONGENITAL MALFORMATION; EPIGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENE MUTATION; GENETIC IDENTIFICATION; GENOME ANALYSIS; GENOMICS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; MICROSATELLITE MARKER; PREVALENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; BRAIN TUMOR; GENE DOSAGE; GENETICS; LASER; MICRODISSECTION; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MICROSATELLITE DNA;

ADULT; AGED; BRAIN NEOPLASMS; CHILD; FEMALE; GENE DOSAGE; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LASERS; LOSS OF HETEROZYGOSITY; MALE; MICRODISSECTION; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 60549097444     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2008-064     Document Type: Article

References (29)

1. Stupp R, Mason WP, vanden Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.
2. Konopka G, Bonni A. Signaling pathways regulating gliomagenesis. Curr Mol Med. 2003;3:73-84.
3. Rao RD, James CD. Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin Oncol. 2004;31:595-604.
4. Hata N, Yoshimoto K, Yokoyama N, et al. Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis. Clin Chem. 2006;52:370-378.
5. Huang J, Wei W, Zhang J, et al. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics. 2004;1:287-299.
6. Zhao X, Li C, Paez JG, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 2004;64:3060-3071.
7. Walker BA, Leone PE, Jenner MW, et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood. 2006;108:1733-1743.
8. Fitzgibbon J, Smith LL, Raghavan M, et al. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res. 2005;65:9152-9154.
9. Langdon JA, Lamont JM, Scott DK, et al. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma. Genes Chromosomes Cancer. 2006;45;47-60.
10. Hu N, Wang C, Hu Y, et al. Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10K array. BMC Genomics. 2006;7:299.
11. Andersen CL, Wiuf C, Kruh0ffer M, Korsgaard S, 0rntoft TF. Frequent occurrence of uniparental disomy in colorectal cancer. Carcinogenesis. 2007;28:38-48.
12. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozy-gosity data. Bioinformatics. 2004;20:1233-1240.
13. Wang TL, Maierhofer C, Speicher MR, et al. Digital karyotyping. Proc Natl Acad Sci USA. 2002;99:16156-16161.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25:402-408.
15. Yoshimoto K, Iwaki T, Inamura T, Fukui M, Tahira T, Hayashi K. Multiplexed analysis of post-PCR fluorescence-labeled microsatellite alleles and statistical evaluation of their imbalance in brain tumors. Jpn J Cancer Res. 2002;93:284-290.
16. Cianciulli AM, Morace E, Coletta AM, et al. Investigation of genetic alterations associated with development and adverse outcome in patients with astrocytic tumor. J Neurooncol. 2000;48:95-101.
17. Kleihues P, Cavenee WK. World Health Organization classification of tumors: tumors of the nervous system. Lyon, France: IARC Press; 2000:29-39.
18. Calhoun ES, Hucl T, Gallmeier E, et al. Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. Can Res. 2006;66:7290-7298.
19. Kloth JN, Oosting J, van Wezel T, et al. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss if heterozygosity analysis reveals complex genetic alterations in cervical cancer. BMC Genomics. 2007;8:53.
20. James CD, Carlbom E, Nordenskjold M, Collins VP, Cavenee WK. Mitotic recombination of chromosome 17 in astrocytomas. Proc Natl Acad Sci USA. 1989;86:2858-2862.
21. Kotliarov Y, Steed ME, Christopher N, et al. High- resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalance. Can Res. 2006;66:9428-9436.
22. Wong KK, Tsang YT, Chang YM, et al. Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array. Can Res. 2006;66:11172-11178.
23. Wiltshire RN, Rasheed BK, Friedman HS, Friedman AH, Bigner SH. Comparative genetic patterns of glioblastoma multiforme: potential diagnostic tool for tumor classification. Neuro-Oncology. 2000;2:164-173.
24. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA. Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet Cytogenet. 2002;135:147-159.
25. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblas-toma: a population-based study. Can Res. 2004;64:6892-6899.
26. Rasheed BK, McLendon RE, Friedman HS, et al. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene. 1995;10:2243-2246.
27. Karlbom AE, James CD, Boethius J, et al. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet. 1993;92:169-174.
28. Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP. Distinct patterns of deletion on 10p and10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer. 1998;22:9-15.
29. Mariani L, Deiana G, Vassella E, et al. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol. 2006;24:4758-4763.